Alligator Bioscience
0.008
SEK
-1.2 %
Less than 1K followers
ATORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
-1.2%
-78.36%
-61.05%
-65.85%
-92.69%
-91.22%
-92.43%
-96.83%
-99.52%
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Read moreMarket cap
138.63M SEK
Turnover
1.95M SEK
Revenue
57.77M
EBIT %
-396.64 %
P/E
-
Dividend yield-%
-
Financial calendar
27.3
2025
Extraordinary general meeting '24
24.4
2025
Interim report Q1'25
5.7
2025
General meeting '25
All
Webcasts
Press releases
ShowingAll content types
Alligator Bioscience: BioStock: Updated data further bolsters Alligator's mitazalimab
Alligator Bioscience Announces Continued Encouraging Overall Survival Benefit for Mitazalimab
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools